China Jo-Jo Drugstores, Inc

(NASDAQ:CJJD)

Latest On China Jo-Jo Drugstores, Inc (CJJD):

Date/Time Type Description Signal Details
2023-04-18 21:41 ESTNewsChina Jo-Jo Drugstores crashes 58% on $7M equity offeringN/A
2023-01-20 16:29 ESTNewsChina Jo-Jo Drugstores falls 15% on ~$2.63M registered direct offeringN/A
2022-07-28 21:57 ESTNewsChina Jo - Jo Drugstores GAAP EPS of -$0.92, revenue of $164.39MN/A
2022-04-27 20:05 ESTNewsChina Jo-Jo Drugstores regains compliance with Nasdaq minimum bid price ruleN/A
2022-04-06 13:35 ESTNewsChina Jo-Jo Drugstores announces 1-for-12 reverse stock splitN/A
2022-01-26 19:27 ESTNewsNasdaq grants another 180 day extension to China Jo-Jo DrugstoresN/A
2022-01-24 18:31 ESTNewsChina Jo - Jo Drugstores GAAP EPS of -$0.01, revenue of $78.48MN/A
2021-07-21 00:23 ESTNewsChina Jo - Jo Drugstores reports FY resultsN/A
2021-02-14 03:19 ESTFinancialsCompany financials have been released.Neutral
2020-12-23 10:57 ESTNewsChina Jo-Jo Drugstores regains compliance with NasdaqN/A
2020-12-13 03:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 23:39 ESTNewsChina Jo - Jo Drugstores reports Q2 resultsN/A
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-19 08:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:25 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 00:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 15:33 ESTNewsChina Jo - Jo Drugstores reports Q1 resultsN/A
2020-08-14 15:33 ESTNewsChina Jo-Jo Drugstores FQ1 retail business up 12%N/A
2020-07-31 00:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-10 09:36 ESTNewsChina Jo-Jo Drugstores reports FY resultsN/A
2020-07-10 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:21 ESTFinancialsCompany financials have been released.Neutral
2020-06-17 03:04 ESTNewsChina Jo-Jo Drugstores COO resignsN/A
2020-06-01 21:16 ESTNewsChina Jo-Jo Drugstores slides 45% on direct offeringN/A
2020-05-31 16:54 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:28 ESTFinancialsCompany financials have been released.Neutral
2020-04-11 07:50 ESTNewsChina Jo - Jo Drugstores reports Q3 resultsN/A
2020-04-08 04:25 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 12:24 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:33 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 23:25 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:26 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 23:20 ESTFinancialsCompany financials have been released.Neutral
2020-02-16 23:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 23:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:22 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:23 ESTFinancialsCompany financials have been released.Neutral
2020-01-27 23:20 ESTFinancialsCompany financials have been released.Neutral
2020-01-15 23:21 ESTFinancialsCompany financials have been released.Neutral
2019-12-21 23:13 ESTFinancialsCompany financials have been released.Neutral
2019-12-16 23:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 23:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-26 23:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-22 23:19 ESTFinancialsCompany financials have been released.Neutral
2019-11-16 23:13 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-11-14 09:45 ESTNewsChina Jo - Jo Drugstores reports Q2 resultsN/A

About China Jo-Jo Drugstores, Inc (CJJD):

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates dada360.com, an online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms, such as Tmall, JD.com, and Amazon.com. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2020, it had 118 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 10 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

CJJD Quotes by TradingView

See Advanced Chart

General

  • Name China Jo-Jo Drugstores, Inc
  • Symbol CJJD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • Full Time Employees 1,014
  • Last Split Factor1:2
  • Last Split Date2010-04-14
  • Fiscal Year EndMarch
  • IPO Date2008-05-16
  • Gic SectorConsumer Staples
  • Gic GroupFood & Staples Retailing
  • Gic IndustryFood & Staples Retailing
  • Gic SubIndustryDrug Retail
  • Web URLhttp://www.jiuzhou-drugstore.com
View More

Valuation

  • Trailing PE 69
  • Price/Sales (Trailing 12 Mt.) 0.36
  • Price/Book (Most Recent Quarter) 1.75
  • Enterprise Value Revenue 0.7
  • Enterprise Value EBITDA 42.28
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -9%
  • Operating Margin -9%
  • Return on Assets -7%
  • Return on Equity -47%
  • Revenue 127.77 million
  • Earnings Per Share $0.01
  • Revenue Per Share $3.31
  • Gross Profit 25.53 million
  • Quarterly Earnings Growth 6.5%
View More

Highlights

  • Market Capitalization 46.34 million
  • EBITDA 1.91 million
  • Analyst Target Price $7
  • Book Value Per Share $0.67
View More

Share Statistics

  • Shares Outstanding 41.75 million
  • Shares Float 27.46 million
  • % Held by Insiders 2490%
  • % Held by Institutions 18.14%
  • Shares Short 355687
  • Shares Short Prior Month 438266
  • Short Ratio 0.2
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.45
  • 52 Week High $3.46
  • 52 Week Low $0.8
  • 50 Day Moving Average 1.18
  • 200 Day Moving Average 1.06
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

China Jo-Jo Drugstores, Inc (CJJD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

China Jo-Jo Drugstores, Inc (CJJD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-15$N/A-$0.15
2020-09-302020-12-31$30.84 million-$0.15
2020-06-302020-09-30$N/A-$0.04
2020-03-312020-06-30$30.33 million-$0.01$0.00
2019-12-312020-03-31$33.36 million-$0.09
2019-09-302019-12-31$28.35 million$0.02
2019-06-302019-09-30$25.28 million-$0.04
2019-03-312019-06-30$26.45 million-$0.07$0.00
2018-12-312019-03-31$30.92 million$0.10
2018-09-302018-12-31$27.41 million-$0.06
2018-06-302018-09-30$22.77 million-$0.06
2018-03-312018-06-30$24.14 million-$0.02
2017-12-312018-03-31$26.81 million-$0.51
2017-09-302017-12-31$23.49 million-$0.08
2017-06-302017-09-30$21.67 million-$0.05
2017-03-312017-06-30$19.79 million-$0.06$0.00
2016-12-312017-03-31$20.61 million-$0.21
2016-09-302016-12-31$20.16 million-$0.04
2016-06-302016-09-30$20.94 million$0.01
2016-03-312016-06-30$20.47 million$0.01
2015-12-312016-03-31$24.71 million$0.05
2015-09-302015-12-31$22.58 million-$0.04
2015-06-302015-09-30$21.31 million$0.01
2015-03-312015-06-30$20.67 million$0.01$0.00
2014-12-312015-03-31$21.32 million$0.07
2014-09-302014-12-31$18.44 million$0.01
2014-06-302014-09-30$16.46 million$-0.00
2014-03-312014-06-30$16.13 million-$0.02$0.00
2013-12-312014-03-31$17.83 million-$1.07
2013-09-302013-12-31$16.86 million-$0.64
2013-06-302013-09-30$15.34 million-$0.04
2013-03-312013-06-30$14.39 million-$0.06$0.00
2012-12-312013-03-31$15.6 million-$0.73
2012-09-302012-12-31$26.67 million-$0.26
2012-06-302012-09-30$32.85 million-$0.11
2012-03-312012-06-30$25.06 million$0.04$0.00
2011-12-312012-03-31$25.65 million$0.12
2011-09-302011-12-31$22.23 million$0.12
2011-06-302011-09-30$21.43 million$0.12
2011-03-312011-06-30$21.04 million$0.24$0.00
2010-12-312011-03-31$18.04 million$0.18$0.19-5.37%
2010-09-302010-12-31$15.68 million$0.17$0.17-2.53%
2010-06-302010-08-16$15.21 million$0.17$0.1513.33%
2010-03-312010-06-02$16.31 million$1.50
2009-12-312010-03-03$14.92 million$0.26
2009-09-302009-09-30$12.26 million$0.21
2009-06-302009-06-30$11.68 million$0.22

China Jo-Jo Drugstores, Inc (CJJD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A N/A
Income Before Tax N/A -1.55 million N/A -3.19 million 458105
Selling General Administrative N/A 8.54 million N/A 8.04 million 6.73 million
Gross Profit N/A 7.01 million N/A 5.49 million 7.28 million
Ebit N/A -930858 N/A -1.41 million 552912
Operating Income N/A -1.52 million N/A -2.55 million 552912
Income Tax Expense 1976 N/A 57570 -16 2184
Total Revenue N/A 30.84 million N/A 30.33 million 33.36 million
Cost of Revenue N/A 23.83 million N/A 24.84 million 26.08 million
Total Other Income Expense Net N/A -91822 N/A -339228 -94807
Net Income From Continuing Operations N/A -1.53 million N/A -3.19 million 455921
Net Income Applicable to Common Shares -6.26 million N/A -231509 -2.99 million 531782
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -160608 N/A -3.12 million -87 -201
Change to Liabilities N/A -5.51 million 6.08 million -8.34 million 10.91 million
Total Cash Flow from Investing Activities N/A -1.6 million -3.12 million -268911 -273722
Net Borrowings N/A 162511 6.19 million 6.27 million -1.64 million
Total Cash Flow from Financial Activities -4.92 million N/A 6.32 million 6.32 million -1.64 million
Change to Operating Activities N/A -1.18 million 349865 -2.56 million -335240
Change in Cash 1.8 million N/A 7.09 million -5.39 million 6.14 million
Total Cash from Operating Activities 5.13 million -5.48 million 4.37 million -12.25 million 9.14 million
Depreciation 497616 N/A 509892 546509 552732
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory -1.59 million N/A -1.5 million 1.39 million -2.23 million
Change to Account Receivables -402948 N/A 1.01 million -3.14 million 1.51 million
Other Cash Flow from Financing Activities N/A -56447 121383 51496 1998
Change to Net Income N/A -133873 844450 -806977 -119850
Capital Expenditures 146570 N/A 555340 270077 244366
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A 78.13 million N/A 80.74 million 63.37 million
Total Stockholder Equity N/A 29.36 million N/A 20.59 million 24.06 million
Other Current Liabilities 3.59 million N/A N/A N/A 3.79 million
Total Assets N/A 105.49 million N/A 99.52 million 85.8 million
Common Stock 41752 N/A 37962 32937 32937
Other Current Assets 14.75 million N/A N/A N/A 14.93 million
Retained Earnings -43.07 million -38.13 million -35.32 million -36.4 million -32.11 million
Other Liabilities 15308 N/A 83125 134597 191757
Other Assets 3.52 million N/A 3.25 million 2.25 million 3.36 million
Cash N/A 21.65 million N/A 16.18 million 11.86 million
Total Current Liabilities 55.88 million 58.49 million N/A 57.44 million 45.74 million
Other Stockholder Equity 3.65 million N/A 1.53 million 1.44 million 1.93 million
Property, Plant & Equipment 28.12 million N/A 26.45 million 29.35 million 23.42 million
Total Current Assets 63.09 million 67.81 million N/A 60.99 million 55.29 million
Long Term Investments N/A 4.12 million N/A 2.54 million 9846
Net Tangible Assets 24.58 million N/A 26.46 million 16.2 million 20.35 million
Short Term Investments N/A 163818 N/A 157159 159946
Long Term Debt N/A 3.09 million N/A 4.12 million 4.77 million
Inventory 19.45 million 13.23 million N/A 12.25 million 10.96 million
Accounts Payable 18.06 million 24.9 million N/A 21.56 million 15.87 million

China Jo-Jo Drugstores, Inc (CJJD) Chart:

China Jo-Jo Drugstores, Inc (CJJD) News:

Below you will find a list of latest news for China Jo-Jo Drugstores, Inc (CJJD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

China Jo-Jo Drugstores, Inc (CJJD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

China Jo-Jo Drugstores, Inc (CJJD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020015961/0001213900-20-015961-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1413263/000000000019006734/0000000000-19-006734-index.htm
2019-04-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1413263/000000000019007788/0000000000-19-007788-index.htm
2019-06-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1413263/000000000019009542/0000000000-19-009542-index.htm
2020-07-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1413263/000000000020006596/0000000000-20-006596-index.htm
2017-01-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1413263/000090266417000536/0000902664-17-000536-index.htm
2017-01-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000090266417000537/0000902664-17-000537-index.htm
2016-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390016010794/0001213900-16-010794-index.htm
2016-02-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390016010882/0001213900-16-010882-index.htm
2016-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390016011872/0001213900-16-011872-index.htm
2016-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390016014532/0001213900-16-014532-index.htm
2016-06-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1413263/000121390016014551/0001213900-16-014551-index.htm
2016-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390016015909/0001213900-16-015909-index.htm
2016-08-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390016015911/0001213900-16-015911-index.htm
2016-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390016017815/0001213900-16-017815-index.htm
2016-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390016018363/0001213900-16-018363-index.htm
2016-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390016018370/0001213900-16-018370-index.htm
2017-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017000044/0001213900-17-000044-index.htm
2017-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017000610/0001213900-17-000610-index.htm
2017-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017001166/0001213900-17-001166-index.htm
2017-02-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390017001184/0001213900-17-001184-index.htm
2017-02-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1413263/000121390017001556/0001213900-17-001556-index.htm
2017-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017003231/0001213900-17-003231-index.htm
2017-04-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1413263/000121390017004094/0001213900-17-004094-index.htm
2017-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017006941/0001213900-17-006941-index.htm
2017-06-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1413263/000121390017006960/0001213900-17-006960-index.htm
2017-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017008563/0001213900-17-008563-index.htm
2017-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390017008606/0001213900-17-008606-index.htm
2017-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390017011944/0001213900-17-011944-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390017011947/0001213900-17-011947-index.htm
2018-02-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018001521/0001213900-18-001521-index.htm
2018-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018001801/0001213900-18-001801-index.htm
2018-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390018001859/0001213900-18-001859-index.htm
2018-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018004088/0001213900-18-004088-index.htm
2018-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018004371/0001213900-18-004371-index.htm
2018-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018004373/0001213900-18-004373-index.htm
2018-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018008475/0001213900-18-008475-index.htm
2018-06-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1413263/000121390018008512/0001213900-18-008512-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018008697/0001213900-18-008697-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018010929/0001213900-18-010929-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390018010999/0001213900-18-010999-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018012184/0001213900-18-012184-index.htm
2018-10-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390018014502/0001213900-18-014502-index.htm
2018-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018014512/0001213900-18-014512-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018015227/0001213900-18-015227-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390018015627/0001213900-18-015627-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390018015635/0001213900-18-015635-index.htm
2018-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018016714/0001213900-18-016714-index.htm
2018-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018016715/0001213900-18-016715-index.htm
2018-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018016716/0001213900-18-016716-index.htm
2018-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018016717/0001213900-18-016717-index.htm
2018-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390018016718/0001213900-18-016718-index.htm
2019-01-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1413263/000121390019001163/0001213900-19-001163-index.htm
2019-01-30RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019001406/0001213900-19-001406-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019002439/0001213900-19-002439-index.htm
2019-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390019002441/0001213900-19-002441-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019003471/0001213900-19-003471-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019004047/0001213900-19-004047-index.htm
2019-04-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390019005627/0001213900-19-005627-index.htm
2019-04-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006092/0001213900-19-006092-index.htm
2019-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006208/0001213900-19-006208-index.htm
2019-04-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006278/0001213900-19-006278-index.htm
2019-04-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1413263/000121390019006281/0001213900-19-006281-index.htm
2019-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006385/0001213900-19-006385-index.htm
2019-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006823/0001213900-19-006823-index.htm
2019-04-23DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390019006960/0001213900-19-006960-index.htm
2019-04-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390019007197/0001213900-19-007197-index.htm
2019-04-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1413263/000121390019007396/0001213900-19-007396-index.htm
2019-05-23S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390019009499/0001213900-19-009499-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019011822/0001213900-19-011822-index.htm
2019-07-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1413263/000121390019011825/0001213900-19-011825-index.htm
2019-07-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390019012273/0001213900-19-012273-index.htm
2019-07-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1413263/000121390019012275/0001213900-19-012275-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1413263/000121390019012595/0001213900-19-012595-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019015645/0001213900-19-015645-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390019015651/0001213900-19-015651-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390019023337/0001213900-19-023337-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390019023368/0001213900-19-023368-index.htm
2020-01-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1413263/000121390020001478/0001213900-20-001478-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020003765/0001213900-20-003765-index.htm
2020-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390020003935/0001213900-20-003935-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020005739/0001213900-20-005739-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020013867/0001213900-20-013867-index.htm
2020-06-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1413263/000121390020013962/0001213900-20-013962-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020014010/0001213900-20-014010-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020014984/0001213900-20-014984-index.htm
2020-06-16DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1413263/000121390020015054/0001213900-20-015054-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020015961/0001213900-20-015961-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020017145/0001213900-20-017145-index.htm
2020-07-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1413263/000121390020017170/0001213900-20-017170-index.htm
2020-07-14S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1413263/000121390020017432/0001213900-20-017432-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020022079/0001213900-20-022079-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1413263/000121390020022155/0001213900-20-022155-index.htm
2020-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1413263/000121390020022807/0001213900-20-022807-index.htm
2020-09-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1413263/000121390020026441/0001213900-20-026441-index.htm
2020-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020032711/0001213900-20-032711-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1413263/000121390020033961/0001213900-20-033961-index.htm
2017-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1413263/000121465917001173/0001214659-17-001173-index.htm
2019-03-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1413263/000121465919002151/0001214659-19-002151-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1413263/000153561019000085/0001535610-19-000085-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1413263/000153561020000022/0001535610-20-000022-index.htm
2019-04-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1413263/999999999519000664/9999999995-19-000664-index.htm
2019-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1413263/999999999519000985/9999999995-19-000985-index.htm
2019-07-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1413263/999999999519001612/9999999995-19-001612-index.htm
2020-08-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1413263/999999999520002231/9999999995-20-002231-index.htm

China Jo-Jo Drugstores, Inc (CJJD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of China Jo-Jo Drugstores, Inc (CJJD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2490%
Institutional Ownership: 1814%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-03-30Ming ZhaoChief Financial OfficerBuy30,000.00199,000.00https://www.sec.gov/Archives/edgar/data/1413263/000121390018004371/0001213900-18-004371-index.htm
2016-10-11Lei LiuCEO, Chairman of the BoardBuy949,000.001.691,603,810.008,150,482.00https://www.sec.gov/Archives/edgar/data/1413263/000121390016017815/0001213900-16-017815-index.htm
2018-03-30Lei LiuCEO, Chairman of the BoardBuy900,000.009,050,482.00https://www.sec.gov/Archives/edgar/data/1413263/000121390018004373/0001213900-18-004373-index.htm